Azora Therapeutics (AZR) Net Income by Year
Azora Therapeutics, Inc. reported a net loss of $8.0M in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $57.8M net loss. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters Azora Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
AZR Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
AZR Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Azora Therapeutics, Inc. financials
Frequently Asked Questions
Azora Therapeutics, Inc. reported a net loss of $8.0M in fiscal year 2025.
Azora Therapeutics, Inc. (AZR) reported a $13.2M net loss in fiscal year 2024 and a $8.0M net loss in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
Azora Therapeutics, Inc. (AZR) reported a $57.8M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
Azora Therapeutics, Inc. (AZR) reported -$52.0M in net income in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Azora Therapeutics, Inc. (AZR) reported on that line in every period on record.